Kidney Cyst Resolution and Management

Introduction to Kidney Cysts

• Simple cysts are extremely common, affecting approximately 50% of individuals older than 50 years, and do not require routine surveillance or follow-up when asymptomatic, as recommended by the American College of Physicians 1

Polycystic Kidney Disease (ADPKD/ARPKD)

• Cysts in hereditary polycystic kidney disease do not resolve and progressively increase in number and size over time, according to the National Kidney Foundation 2, 3, 4
• PKD1 mutations cause more severe disease progression than PKD2 mutations, as stated by the American Society of Nephrology 4
• The Mayo Imaging Classification uses height-adjusted total kidney volume to stratify patients into 5 groups (1A-1E) indicating accelerating decline in kidney function, as recommended by the National Institute of Diabetes and Digestive and Kidney Diseases 2, 3

Diagnostic Considerations

• A normal fetal or childhood ultrasound does not exclude ADPKD in at-risk children, as cysts develop gradually and may not be detectable early in milder phenotypes, according to the American Academy of Pediatrics 4
• If kidney ultrasonography is normal in an at-risk child, rescreening should occur at intervals no shorter than 3 years, as recommended by the Society for Pediatric Radiology 5

Acquired Cystic Disease (ACD)

• Acquired cystic disease occurs exclusively in end-stage renal disease and does not resolve; cysts increase with duration of hemodialysis, as stated by the National Kidney Foundation 4
• Duration of hemodialysis directly correlates with increased cyst occurrence, according to the American Society of Nephrology 4
• Male gender is associated with higher risk of developing ACD, as reported by the International Society of Nephrology 4

Clinical Management

• For simple cysts, routine surveillance has minimal impact on diagnosis and management in patients with kidney disease, hypertension, or diabetes, as recommended by the American College of Physicians 1
• Ultrasound may be indicated when there is prior history of stones or obstruction, frequent urinary tract infections, or family history of ADPKD, according to the American Institute of Ultrasound in Medicine 1
• Complex cysts with septations, calcifications, internal echoes, or irregularities need further characterization due to malignancy risk, as stated by the American College of Radiology 1

Differential Diagnosis of Polycystic Kidney Disease

Key Differentials to Consider

• The American Academy of Pediatrics and the National Institute of Diabetes and Digestive and Kidney Diseases recommend considering Autosomal Recessive Polycystic Kidney Disease (ARPKD) in neonates or early childhood with bilaterally enlarged echogenic kidneys and hepatic fibrosis 6
• The European Society of Human Genetics and the American Society of Nephrology suggest that PKD1/TSC2 contiguous gene syndrome presents with severe polycystic kidney disease in infancy or early childhood combined with tuberous sclerosis features, and requires referral to specialized centers for multidisciplinary management 6, 7, 8

Diagnostic Approach Algorithm

• The American College of Cardiology recommends that a positive family history with similar phenotype suggests ADPKD is most likely, with a study published in the European Heart Journal in 2013 9
• The European Association for the Study of the Liver recommends that liver cysts, present in 44-80% of ADPKD patients, strongly support ADPKD diagnosis, as reported in the Journal of Hepatology in 2022 10

Management Implications Based on Differential

• The National Institute of Diabetes and Digestive and Kidney Diseases and the American Heart Association recommend blood pressure control with ACE inhibitors or ARBs as cornerstone therapy for ADPKD, targeting 110/75 mmHg for ages 18-49 with CKD G1-G2, or systolic <120 mmHg for age ≥50 or CKD G3-G5, and avoiding chronic NSAID use for pain management 7
• The American Society of Nephrology suggests that tolvaptan should be considered for adults at high risk of rapid progression based on Mayo Imaging Classification and total kidney volume, slowing eGFR decline by 1.3 mL/min/1.73m²/year, as reported in Nature Reviews Nephrology in 2019 7, 8

Evaluation and Management of Multiple Renal Cysts with a Dominant Lesion

Diagnostic Workup

• Obtain a three‑generation family history that includes kidney disease, dialysis, transplantation, cerebral aneurysms, and early cardiovascular death to help differentiate hereditary cystic disorders. 11, 12
• Recognize that approximately 50 % of autosomal dominant polycystic kidney disease (ADPKD) cases arise de novo, so a negative family history does not rule out ADPKD. 11, 13
• Assess imaging for a bilateral, diffuse cyst distribution (typical ADPKD) versus unilateral, segmental, asymmetric, or lopsided patterns (atypical ADPKD). 11, 13
• Measure serum creatinine and calculate estimated glomerular filtration rate (eGFR) to determine baseline kidney function. 11, 13
• Record blood pressure because early‑onset hypertension is common in ADPKD and influences prognosis. 11
• Perform urinalysis to screen for proteinuria or hematuria. 11

Risk Stratification in Confirmed ADPKD

• Compute height‑adjusted total kidney volume (htTKV) and apply the Mayo Imaging Classification (classes 1A‑1E) to predict the rate of renal function decline. 11, 13

Medical Management

• Aim for systolic blood pressure < 120 mmHg in patients ≥ 50 years or with CKD stages 3‑5, and 110/75 mmHg in patients 18‑49 years with CKD stages 1‑2; use ACE inhibitors or ARBs as first‑line agents. 11

Interventional Management of Symptomatic Cysts

• For severe, refractory pain from a large cyst, consider percutaneous cyst aspiration followed by ethanol sclerotherapy (≈ 97 % efficacy) or laparoscopic decortication. 11
• Reserve nephrectomy for cases of severe, intractable pain when accompanied by advanced kidney disease or end‑stage renal failure. 11, 13

Pediatric Considerations

• In children, multiple renal cysts strongly suggest ADPKD or other cystic nephropathies; a comprehensive work‑up should include parental renal ultrasonography. 12
• Ultrasound is the preferred diagnostic modality in pediatric patients; magnetic resonance imaging is not recommended for children < 15 years due to lack of validated criteria and the need for sedation. 12
• If an at‑risk child has a normal ultrasound, schedule repeat screening at intervals of at least three years. 12

Clinical Pitfalls

• Do not postpone blood‑pressure control or imaging‑based risk stratification in ADPKD, as early intervention improves long‑term kidney survival. 11